XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Retained Income [Member]
Retained Income [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Accumulated Other Comprehensive Income, Net of Tax [Member]
Total Stockholders' Equity [Member]
Total Stockholders' Equity [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Noncontrolling Interests [Member]
Beginning Balance at Dec. 31, 2020 $ 201,136 $ (3,018)     $ 199,592 $ (3,018) $ 1,544 $ 201,136 $ (3,018)
Beginning Balance, shares at Dec. 31, 2020     7,785,617              
Net income (loss) 6,845       6,942     6,942   (97)
Net income attributable to redeemable noncontrolling interest (Note 17) (794)       (794)     (794)    
Total other comprehensive income (loss), net of income taxes (140)           (139) (139)   (1)
Issuance of restricted stock 0   $ 0 $ 0 0   0 0   0
Issuance of restricted stock, shares     548,086              
Forfeiture of restricted stock, value 0   $ 0 0 0   0 0   0
Forfeiture of restricted stock, shares     (2,050)              
Cancellation of restricted stock, shares     (141,600)              
Repurchase and retirement of common stock, value (20)     (20)       (20)    
Repurchase and retirement of common stock, shares     (371)              
Issuance of common stock 5,410     5,410       5,410    
Issuance of common stock, shares     100,000              
Dilution from subsidiary stock-based compensation 215                 215
Issuance of warrants, net of issuance costs (Note 18) 8,640     8,640       8,640    
Common stock dividends (2,793)       (2,793)     (2,793)    
Stock-based compensation 2,127     2,127       2,127    
Additional paid-in capital shortfall adjustment allocated to retained income       16,157 (16,157)          
Ending Balance at Mar. 31, 2021 217,608       216,086   1,405 217,491   117
Ending Balance, shares at Mar. 31, 2021     8,289,682              
Beginning Balance at Dec. 31, 2021 324,503     76,077 246,790   498 323,365   1,138
Beginning Balance, shares at Dec. 31, 2021     10,131,399              
Net income (loss) 2,791       2,978     2,978   (187)
Net income attributable to redeemable noncontrolling interest (Note 17) (2,248)       (2,075)     (2,075)   (173)
Total other comprehensive income (loss), net of income taxes (2,784)           (2,683) (2,683)   (101)
Issuance of restricted stock 0   $ 0 0 0   0 0   0
Issuance of restricted stock, shares     4,000              
Forfeiture of restricted stock, value 0   $ 0 0 0   0 0   0
Forfeiture of restricted stock, shares     (3,265)              
Repurchase and retirement of common stock, value (398)     (398)       (398)    
Repurchase and retirement of common stock, shares     (6,207)              
Dilution from subsidiary stock-based compensation 758                 758
Common stock dividends (4,046)       (4,046)     (4,046)    
Stock-based compensation 3,452     3,452       3,452    
Ending Balance at Mar. 31, 2022 $ 322,028     $ 79,131 $ 243,647   $ (2,185) $ 320,593   $ 1,435
Ending Balance, shares at Mar. 31, 2022     10,125,927